134 related articles for article (PubMed ID: 36999379)
1. The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia.
Poetsch MS; Palus S; Van Linthout S; von Haehling S; Doehner W; Coats AJS; Anker SD; Springer J
Eur J Heart Fail; 2023 May; 25(5):673-686. PubMed ID: 36999379
[TBL] [Abstract][Full Text] [Related]
2. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
3. The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model.
Yuan L; Springer J; Palus S; Busquets S; Jové Q; Alves de Lima Junior E; Anker MS; von Haehling S; Álvarez Ladrón N; Millman O; Oosterlee A; Szymczyk A; López-Soriano FJ; Anker SD; Coats AJS; Argiles JM
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):653-660. PubMed ID: 36346141
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.
Palus S; von Haehling S; Flach VC; Tschirner A; Doehner W; Anker SD; Springer J
Int J Cardiol; 2013 Oct; 168(4):3412-8. PubMed ID: 23680591
[TBL] [Abstract][Full Text] [Related]
5. MT-102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia.
Pötsch MS; Ishida J; Palus S; Tschirner A; von Haehling S; Doehner W; Anker SD; Springer J
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):594-605. PubMed ID: 32067370
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
[TBL] [Abstract][Full Text] [Related]
7. Cardiac expression of neutrophil gelatinase-associated lipocalin in a model of cancer cachexia-induced cardiomyopathy.
Musolino V; Palus S; Latouche C; Gliozzi M; Bosco F; Scarano F; Nucera S; Carresi C; Scicchitano M; von Haehling S; Jaisser F; Hasenfuss G; Anker SD; Mollace V; Springer J
ESC Heart Fail; 2019 Feb; 6(1):89-97. PubMed ID: 30367561
[TBL] [Abstract][Full Text] [Related]
8. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia.
Saitoh M; Hatanaka M; Konishi M; Ishida J; Palus S; Ebner N; Döhner W; von Haehling S; Anker SD; Springer J
Int J Cardiol; 2016 Sep; 218():312-317. PubMed ID: 27240157
[TBL] [Abstract][Full Text] [Related]
10. The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy.
Springer J; Tschirner A; Hartman K; von Haehling S; Anker SD; Doehner W
Int J Cardiol; 2013 Oct; 168(4):3527-31. PubMed ID: 23751350
[TBL] [Abstract][Full Text] [Related]
11. Effects of S-pindolol in mouse pancreatic and lung cancer cachexia models.
Springer J; Jové Q; de Lima Junior EA; Ladrón NÁ; López-Soriano FJ; Busquets S; Argiles JM; Marks DL
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1244-1248. PubMed ID: 37130578
[TBL] [Abstract][Full Text] [Related]
12. Febuxostat improves outcome in a rat model of cancer cachexia.
Konishi M; Pelgrim L; Tschirner A; Baumgarten A; von Haehling S; Palus S; Doehner W; Anker SD; Springer J
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):174-80. PubMed ID: 26136193
[TBL] [Abstract][Full Text] [Related]
13. Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
Springer J; Tschirner A; Haghikia A; von Haehling S; Lal H; Grzesiak A; Kaschina E; Palus S; Pötsch M; von Websky K; Hocher B; Latouche C; Jaisser F; Morawietz L; Coats AJ; Beadle J; Argiles JM; Thum T; Földes G; Doehner W; Hilfiker-Kleiner D; Force T; Anker SD
Eur Heart J; 2014 Apr; 35(14):932-41. PubMed ID: 23990596
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
[TBL] [Abstract][Full Text] [Related]
15. The erythropoietin-derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia.
Palus S; Elkina Y; Braun T; von Haehling S; Döhner W; Anker SD; Cerami A; Brines M; Springer J
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2202-2210. PubMed ID: 35586884
[TBL] [Abstract][Full Text] [Related]
16. IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia.
Schmidt K; von Haehling S; Doehner W; Palus S; Anker SD; Springer J
J Cachexia Sarcopenia Muscle; 2011 Jun; 2(2):105-109. PubMed ID: 21766056
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial.
Clark AL; Coats AJS; Krum H; Katus HA; Mohacsi P; Salekin D; Schultz MK; Packer M; Anker SD
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):549-556. PubMed ID: 28244261
[TBL] [Abstract][Full Text] [Related]
18. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M
Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031
[TBL] [Abstract][Full Text] [Related]
19. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure.
Nagaya N; Uematsu M; Kojima M; Ikeda Y; Yoshihara F; Shimizu W; Hosoda H; Hirota Y; Ishida H; Mori H; Kangawa K
Circulation; 2001 Sep; 104(12):1430-5. PubMed ID: 11560861
[TBL] [Abstract][Full Text] [Related]
20. ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia.
Huot JR; Pin F; Narasimhan A; Novinger LJ; Keith AS; Zimmers TA; Willis MS; Bonetto A
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1779-1798. PubMed ID: 33200567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
